Rimegepant

🧮 Dose calculator

Acute migraine attack · Regimen source: FDA Nurtec ODT · 2.1

• • Safety of more than 18 doses in 30 days not established. On or under the tongue, no water needed. FDA Nurtec ODT · 2.1FDA Nurtec ODT · 2.3

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Nurtec ODT · 8.1

  “Risk Summary There are no adequate data on the developmental risk associated with the use of NURTEC ODT in pregnant women.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Nurtec ODT · 8.2

  “Risk Summary A lactation study was conducted, and the results have established a relative infant dose of less than 1% of the maternal weight-adjusted dose and the milk-to-plasma ratio of 0.20 (see Data ) .”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Nurtec ODT · 8.4

  “Safety and effectiveness in pediatric patients have not been established.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Nurtec ODT · 8.5

  “In pharmacokinetic studies, no clinically significant pharmacokinetic differences were observed between elderly and younger subjects.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.